Publication | Open Access
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma
193
Citations
59
References
2018
Year
Novartis, NIH, Conquer Cancer Foundation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1